RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5256
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1418100; Gene model (P.falciparum): PF3D7_1319600; Gene product: ACDC domain-containing protein, putative (AP2R-2 (AP2 Transcription Factor-related gene 2))
Name tag: GFP
Phenotype Gametocyte/Gamete;
Last modified: 14 February 2023, 15:01
  *RMgm-5256
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 36780562
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-4870
Other information parent lineThe mutant (RMgm-4870) contains a gene encoding Cas9 from Streptococcus pyogenes, introduced into the c/d-ssu-rrna gene. This Cas9 nuclease does not cleave double-stranded DNA in the absence of sgRNA and is thus suitable for generating the parasite which expresses it constitutively. It does not contain a drug-selectable marker that has been removed by negative selection
The mutant parasite was generated by
Name PI/ResearcherNishi T, Yuda M
Name Group/DepartmentLaboratory of Medical Zoology, Department of Medicine
Name InstituteMie University
CityMie, Tsu
CountryJapan
Name of the mutant parasite
RMgm numberRMgm-5256
Principal nameAP2-R2::GFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteAP2-R2 expression was observed in the nucleus of female gametocytes
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of AP2-R2.
In addition, the mutant contains a gene encoding Cas9 from Streptococcus pyogenes, introduced into the c/d-ssu-rrna gene. This Cas9 nuclease does not cleave double stranded DNA in the absence of sgRNA and is thus suitable for generating the parasite which express it constitutively. It does not contain a drug-selectable marker which has been removed by negative selection.

Protein (function)
In Plasmodium spp., sexual development is triggered by AP2-G. It is an AP2-family transcription factor that is expressed in a subpopulation of blood-stage parasites, with disruption of the gene resulting in complete loss of the parasite’s capability to produce gametocytes. The target genes of AP2-G includes a female-specific transcription factor gene, ap2-fg. AP2-FG activates most female-specific genes, and disruption of this gene results in the formation of abnormal female gametocytes. Ap2-o3 (ap2-fg2) and ap2r-2 are also a target gene of AP2-G.It has been reported that in both P. berghei and P. yoelii, disruption of ap2-o3 results in arrest of parasite development during ookinete development (and therefore the name ap2-o3. AP2-R2, on the other hand, is expressed in female gametocytes, and disruption of this gene impairs ookinete development.

Previously  two putative transcriptional regulator genes were identified, ap2r-1 and ap2r-2, as a target gene of AP2-G and AP2-FG. Of these, ap2r-1 functions as a transcriptional activator in zygotes and is renamed ap2-z, but the functional role of ap2r-2 remains unknown. AP2R-2 has an ACDC domain at its C-terminus, but no AP2 domain. It is expressed in females, and ap2r-2 knockout parasites [ap2r-2(-)] are not able to form banana-shaped ookinetes.

Here, we report that PbAP2-O3 and  AP2R-2 are expressed in female gametocytes and function together as a transcriptional repressor complex in P. berghei. Accordingly, we renamed PbAP2-O3 PbAP2-FG2.

Phenotype

AP2-R2 expression was observed in the nucleus of female gametocytes.

Ap2r-2 knockout parasites [ap2r-2(-)] (RMgm-5033) are not able to form banana-shaped ookinetes.
Analyses of a mutant lacking expression of PbAP2-FG2 (RMgm-5254) showed the following: The mutant formed morphologically normal female and male gametocytes, and the male gametocytes showed normal exflagellation. Pbap2-fg2(-) parasites failed to produce banana-shaped ookinetes; more than half of the fertilized population stopped developing at round zygotes, and the others, at retort-form ookinetes. No oocyst/sporozoite formation.


Additional information
Evidence is presented that:
- Crossing experiments showed that Pbap2-fg2(-) parasites produce fertile males; only females are 'infertile' and produce aberrant ookinetes
- Disruption of pbap2-fg2 affected the female transcriptome, causing downregulation of female-enriched genes
- Target genes of PbAP2-FG2 were upregulated in ap2-fg2(-)
- The binding motifs of PbAP2-FG2 functioned as a cis-acting repressive element. PbAP2-FG2 functions as a transcriptional repressor.
- PbAP2-FG2 requires a co-repressor AP2R-2 (PBANKA_1418100; PF3D7_1319600) to repress its target genes.
Previously  two putative transcriptional regulator genes were identified, ap2r-1 and ap2r-2, as a target gene of AP2-G and AP2-FG. Of these, ap2r-1 functions as a transcriptional activator in zygotes and is renamed ap2-z, but the functional role of ap2r-2 remains unknown. AP2R-2 has an ACDC domain at its C-terminus, but no AP2 domain. It is expressed in females, and ap2r-2 knockout parasites [ap2r-2(-)] are not able to form banana-shaped ookinetes.
- PbAP2-FG2 and AP2R-2 repress the target genes of AP2-G
- The function of PyAP2-FG2 is identical to that of PbAP2-FG2.
The analyses revealed that PbAP2-FG2 and PyAP2-FG2 both repress not only male genes but also a wide-variety of genes to support female differentiation.

Other mutants

 


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1418100
Gene Model P. falciparum ortholog PF3D7_1319600
Gene productACDC domain-containing protein, putative
Gene product: Alternative nameAP2R-2 (AP2 Transcription Factor-related gene 2)
Details of the genetic modification
Name of the tagGFP
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe transgenic parasites were generated by the CRISPR/Cas9 system using the parasites expressing Cas9 (RMgm-4870). The Cas9-expressing parasite Pbcas9 has a cas9 cassette at the p230p locus. The hsp70 promoter controls the expression of Cas9, and Pbcas9 constitutively expresses Cas9 throughout the asexual blood cycle. Donor DNA for transfection was constructed by overlap PCR, cloned into pBluescript KS (+) using the XhoI and BamHI sites by In-Fusion cloning, and then amplified by PCR from the constructed plasmid. sgRNA vectors were constructed as previously described. Target sites of sgRNA were designed using the online tool CHOPCHOP (https://chopchop.cbu.uib.no/).
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6